Sio Capital Management as of June 30, 2023
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 46 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ge Healthcare Technologies I Common Stock (GEHC) | 12.4 | $49M | 600k | 81.24 | |
| Shockwave Med Put Option (SWAV) | 11.2 | $44M | 154k | 285.41 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 8.7 | $34M | 142k | 241.33 | |
| Cigna Corp (CI) | 8.0 | $32M | 113k | 280.60 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 6.3 | $25M | 969k | 25.52 | |
| Stryker Corporation Put Option (SYK) | 6.2 | $24M | 80k | 305.09 | |
| United Therapeutics Corporation (UTHR) | 4.5 | $18M | 80k | 220.75 | |
| Medifast Put Option (MED) | 4.5 | $18M | 190k | 92.16 | |
| GSK Sponsored Adr (GSK) | 4.3 | $17M | 480k | 35.64 | |
| Globus Med Cl A (GMED) | 3.2 | $13M | 213k | 59.54 | |
| Align Technology Put Option (ALGN) | 3.1 | $12M | 35k | 353.64 | |
| Intuitive Surgical Com New Put Option (ISRG) | 3.1 | $12M | 36k | 341.94 | |
| Adc Therapeutics Sa SHS (ADCT) | 2.2 | $8.6M | 4.0M | 2.15 | |
| Viking Therapeutics (VKTX) | 2.2 | $8.6M | 528k | 16.21 | |
| Organon & Co Common Stock (OGN) | 2.1 | $8.4M | 405k | 20.81 | |
| Axonics Modulation Technolog (AXNX) | 2.1 | $8.3M | 164k | 50.47 | |
| Patterson Companies (PDCO) | 2.1 | $8.1M | 245k | 33.26 | |
| Humana (HUM) | 1.5 | $5.8M | 13k | 447.13 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.4 | $5.4M | 877k | 6.19 | |
| ImmunoGen | 1.2 | $4.6M | 246k | 18.87 | |
| Nektar Therapeutics (NKTR) | 1.0 | $4.0M | 7.0M | 0.58 | |
| Silverback Therapeutics (SPRY) | 0.9 | $3.6M | 543k | 6.70 | |
| Revance Therapeutics (RVNC) | 0.9 | $3.6M | 142k | 25.31 | |
| Merrimack Pharmaceuticals In Com New (MACK) | 0.9 | $3.6M | 291k | 12.30 | |
| X4 Pharmaceuticals (XFOR) | 0.9 | $3.4M | 1.7M | 1.94 | |
| Savara (SVRA) | 0.8 | $3.2M | 1.0M | 3.19 | |
| Arcutis Biotherapeutics (ARQT) | 0.7 | $2.8M | 293k | 9.53 | |
| Viewray (VRAYQ) | 0.6 | $2.3M | 6.4M | 0.35 | |
| Ideaya Biosciences (IDYA) | 0.4 | $1.8M | 75k | 23.50 | |
| Nyxoah S A SHS (NYXH) | 0.4 | $1.6M | 200k | 8.01 | |
| Inogen (INGN) | 0.3 | $1.3M | 112k | 11.55 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.3 | $1.2M | 150k | 7.84 | |
| Fusion Pharmaceuticals (FUSN) | 0.3 | $1.1M | 246k | 4.67 | |
| Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.2 | $928k | 254k | 3.65 | |
| Aprea Therapeutics Com New (APRE) | 0.2 | $882k | 280k | 3.15 | |
| Repare Therapeutics Ord (RPTX) | 0.2 | $805k | 76k | 10.58 | |
| Vanda Pharmaceuticals (VNDA) | 0.2 | $676k | 103k | 6.59 | |
| Modular Med Com New (MODD) | 0.2 | $676k | 689k | 0.98 | |
| Nextcure (NXTC) | 0.1 | $234k | 130k | 1.80 | |
| Moleculin Biotech | 0.0 | $176k | 303k | 0.58 | |
| Vincerx Pharma Com New (VINC) | 0.0 | $133k | 102k | 1.30 | |
| Caremax Com Cl A | 0.0 | $96k | 31k | 3.11 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $78k | 400k | 0.20 | |
| Fibrogen (FGEN) | 0.0 | $63k | 23k | 2.70 | |
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $36k | 50k | 0.72 | |
| Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $4.7k | 13k | 0.37 |
